Feasibility study of combination Docetaxel, Cisplatin, and S-1 as neoadjuvant chemotherapy for advanced gastric cancer.
Not Applicable
Recruiting
- Conditions
- gastric cancer
- Registration Number
- JPRN-UMIN000005984
- Lead Sponsor
- Sapporo Medical University School of Medicine Dept. of Internal Medicine(4)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1) History of hypersensitivity to DCS. 2) Contraindication to Docetaxel, CDDP, S-1, G-CSF. 3) Infectious disease. 4) Severe complication. 5) Neuropathy greater than grade 2. 6) Watery diarrhea. 7) Active double cancer. 8) Persons to be pregnant or to make pregnant.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method